We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+6.94%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$54.2B
AUM Growth
+$30.1B
(+125%)
Cap. Flow
+$28.6B
Cap. Flow
% of AUM
52.81%
Top 10 Holdings %
Top 10 Hldgs %
15.56%
Holding
4,600
New
1,635
Increased
1,281
Reduced
635
Closed
782
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.08B |
| 2 |
Amazon
AMZN
|
+$1B |
| 3 |
Meta Platforms (Facebook)
META
|
+$844M |
| 4 |
Apple
AAPL
|
+$842M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$725M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$192M |
| 2 |
West Pharmaceutical
WST
|
+$107M |
| 3 |
Advanced Micro Devices
AMD
|
+$97.2M |
| 4 |
Bio-Rad Laboratories Class A
BIO
|
+$79.3M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$79.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.77% |
| 2 | Healthcare | 17.47% |
| 3 | Financials | 15.58% |
| 4 | Consumer Discretionary | 12.3% |
| 5 | Communication Services | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Ulta Beauty
ULTA
$22B
| $83.4M | 0.15% |
202,347
+164,587
| +436% | +$63.9M |
|
127
Datadog
DDOG
$95.4B
| $83M | 0.15% |
466,000
+361,765
| +347% | +$61.4M |
|
128
Inspire Medical Systems
INSP
$1.45B
| $81.8M | 0.15% |
355,561
-10,588
| -3% | -$2.59M |
|
129
Regeneron Pharmaceuticals
REGN
$78.5B
| $81.5M | 0.15% |
129,028
+25,056
| +24% | +$15.4M |
|
130
MetLife
MET
$61.9B
| $80.7M | 0.15% |
1,290,912
+893,806
| +225% | +$56.1M |
|
|
INFO
131
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $80.4M | 0.15% |
605,225
+276,077
| +84% | +$35.2M |
|
132
KLA
KLAC
$239B
| $79.4M | 0.15% |
1,846,600
+1,716,470
| +1,319% | +$66.2M |
|
133
Marriott International
MAR
$98.3B
| $78.9M | 0.15% |
477,325
+463,367
| +3,320% | +$72.9M |
|
134
Applovin
APP
$133B
| $78.4M | 0.14% |
831,770
+464,660
| +127% | +$43.3M |
|
135
US Foods
USFD
$22.2B
| $77M | 0.14% |
2,209,353
+2,136,212
| +2,921% | +$74.4M |
|
136
CALL
iShares Russell 2000 ETF
IWM
$79.8B
| $76.8M | 0.14% |
345,400
-808,300
| -70% | -$183M |
|
137
PUT
Micron Technology
MU
$930B
| $75M | 0.14% |
804,800
+602,900
| +299% | +$47.1M |
|
138
Revolve Group
RVLV
$1.8B
| $74.6M | 0.14% |
1,330,838
+959,875
| +259% | +$67.5M |
|
|
PDCE
139
DELISTED
PDC Energy, Inc.
PDCE
| $74.1M | 0.14% |
+1,518,397
| New | +$77.9M |
|
140
Cboe Global Markets
CBOE
$32.5B
| $74M | 0.14% |
+567,638
| New | +$73.2M |
|
141
SkinHealth Systems
SKIN
$88.8M
| $73.2M | 0.14% |
3,027,938
-1,085,492
| -26% | -$28M |
|
142
Blackrock
BLK
$169B
| $71.8M | 0.13% |
78,382
+42,271
| +117% | +$38.6M |
|
|
SBNY
143
DELISTED
Signature Bank
SBNY
| $71.4M | 0.13% |
+220,662
| New | +$68.8M |
|
144
Constellium
CSTM
$3.76B
| $71.1M | 0.13% |
+3,972,353
| New | +$72.9M |
|
145
SAP
SAP
$212B
| $71.1M | 0.13% |
507,763
+342,546
| +207% | +$47.8M |
|
146
Endava
DAVA
$158M
| $70.3M | 0.13% |
418,717
-159,487
| -28% | -$24.7M |
|
147
Illumina
ILMN
$31B
| $69.9M | 0.13% |
188,791
+47,439
| +34% | +$18M |
|
148
Moody's
MCO
$82.8B
| $68.3M | 0.13% |
174,874
+169,220
| +2,993% | +$65.3M |
|
149
Avient
AVNT
$3.33B
| $67.8M | 0.13% |
+1,212,095
| New | +$66.3M |
|
150
Dillards
DDS
$9.19B
| $67.7M | 0.13% |
276,433
+178,137
| +181% | +$46.9M |
|
Similar funds
Marshall Wace's Q4 2021 Portfolio in Review
As of Q4 2021, Marshall Wace held 4,600 positions worth $54.2B, up 125% from $24.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Marshall Wace deployed $28.6B of net new capital in Q4 2021, opening 1,635 new positions and adding to 1,281 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 1,140,732 shares worth $542M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Accenture, an estimated $192M trimmed.
- Marshall Wace's largest Q4 2021 buy was State Street SPDR S&P 500 ETF Trust: 1,140,732 shares worth $542M.
- Marshall Wace added most to Microsoft in Q4 2021, an estimated $1.08B increase.
- Marshall Wace's biggest Q4 2021 reduction was Accenture, cutting an estimated $192M.
- Marshall Wace fully exited Sabre in Q4 2021, selling an estimated $44.1M.
- Marshall Wace's ten largest holdings make up 16% of its $54.2B portfolio in Q4 2021.
- Marshall Wace opened 1,635 new positions and closed 782 in Q4 2021.
- Marshall Wace's portfolio value rose 125% quarter-over-quarter to $54.2B.
Based on Marshall Wace's 13F filing for Q4 2021, filed 14 Feb 2022.